50 results on '"Kupper, T."'
Search Results
2. 058 Tissue-resident memory T cells in tumor immunity
Catalog
Books, media, physical & digital resources
3. 085 Senescent dendritic cells drive ROS-induced DNA damage in CTCL
4. 060 Heterogeneity and lineage development of memory CD8+ T cells after viral infection of skin
5. 820 Have FOXP3, will travel: Human treg preferentially recirculate and suppress the activation of skin resident effector T cells
6. 059 Enhanced and suppressed tumor immunity is mediated by IL-1R1 on distinct immune cells
7. 605 Phototherapy-induced IFNκ drives type I IFN induced anticancer responses in CTCL
8. 055 CD8 T cell immunity after respiratory viral infection is transient, while CD8 T cell immunity after epidermal vaccination is lung focused and durable
9. LB873 IL-1R1 on distinct immune cells can strongly enhance or inhibit tumor immunity
10. LB1018 Regulatory T cells inhibit CD8+ TRM-like cells during the early stages of tumor immune escape
11. 674 Analysis of human skin aging and implications for rejuvenating with secreted proteins
12. 037 Allergen-specific immunotherapy drives the peripheral-induced RORγt-expressing skin resident Treg cells for atopic dermatitis
13. 1032 Glycolipid antigens presented by CD1 may drive T cell activation in cutaneous T cell lymphoma
14. 1015 Radiation therapy eradicates malignant T cells and is associated with improved survival in early-stage mycosis fungoides
15. 1029 High throughput TCR sequencing greatly improves prediction of recurrence in primary melanomas
16. 088 Skin delivery of modified vaccinia ankara (MVA) virus generates superior protective pulmonary immunity
17. 492 Identification of skin-resident Treg cells in allergen-specific immunotherapy mouse model
18. 983 Fatty-acid-binding protein 5 induces Th17 polarization in atopic dermatitis patients with allergic march
19. 092 Approaches to generating protective T cell vaccines to conserved influenza epitopes using Modified Vaccinia Ankara (MVA) vector vaccines delivered through skin
20. LB1018 Regulatory T cells inhibit CD8+TRM-like cells during the early stages of tumor immune escape
21. 037 Allergen-specific immunotherapy drives the peripheral-induced RORγt-expressing skin resident Tregcells for atopic dermatitis
22. 022 Distinct transcriptome signature of skin-resident memory T cells and migratory memory T cells in atopic dermatitis
23. 109 A primary role for human central memory cells in tissue immunosurveillance
24. 106 Early stage mycosis fungoides has a mutanome distinct from Sezary Syndrome
25. 110 Tumor clone frequency is a robust predictor of progression and survival in patients with Stage IB mycosis fungoides
26. 481 Benign T cells drive visible inflammation in cutaneous T cell lymphoma
27. 083 CXCR4-expressing skin-resident NKT cells develop allergic inflammation in atopic dermatitis
28. 053 Lipid scavenger molecule CD36 regulates free fatty acid uptake and peripheral maintenance of tissue resident memory T cells
29. 071 Human central memory T cells generate superior numbers of resident memory T cells in skin
30. 458 CD8+ T cell skin infiltration predicts disease progression in CTCL patients
31. 074 Predicting recurrence in primary melanomas by T cell receptor immunosequencing
32. 056 Skin scarification with modified vaccinia ankara (MVA) virus generates protective pulmonary immunity
33. 076 IL-1β antibody blockade as a novel approach in cancer immunotherapy
34. 055 Tissue resident memory T cell survival requires exogenous lipid uptake and metabolism
35. 062 Human melanoma TILs share phenotypic and transcriptional properties with tissue resident memory T cells
36. 400 The balance between the malignant clone and reactive T-cells in skin reliably predicts progression in CTCL
37. 082 Systemic atopic dermatitis has different immune signatures
38. 064 A murine model to understand the efficacy of smallpox vaccination
39. 314 Preferential expression of PD-1 on malignant T cells of CTCL may underlie disease worsening in patients undergoing anti-PD1 therapy
40. Old meets new: the interaction between innate and adaptive immunity.
41. Inflammatory skin disease in K14/p40 transgenic mice: evidence for interleukin-12-like activities of p40.
42. Interleukin-1 and cutaneous inflammation: a crucial link between innate and acquired immunity.
43. HIV-infected Langerhans cells constitute a significant proportion of the epidermal Langerhans cell population throughout the course of HIV disease.
44. Keratinocyte-derived monocyte chemoattractant protein 1 (MCP-1): analysis in a transgenic model demonstrates MCP-1 can recruit dendritic and Langerhans cells to skin.
45. The interleukin-1 axis and cutaneous inflammation.
46. The activated keratinocyte: a model for inducible cytokine production by non-bone marrow-derived cells in cutaneous inflammatory and immune responses.
47. Biology of the interleukin-1 receptor.
48. Keratinocyte derived T-cell growth factor (KTGF) is identical to granulocyte macrophage colony stimulating factor (GM-CSF).
49. Hydrocortisone reduces both constitutive and UV-elicited release of epidermal thymocyte activating factor (ETAF) by cultured keratinocytes.
50. Keratinocyte membrane-associated epidermal cell-derived thymocyte-activating factor (ETAF).
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.